Publication
A Novel Pyrazolo[1,5-a]pyrimidine Is a Potent Inhibitor of Cyclin-Dependent Protein Kinases 1, 2, and 9, Which Demonstrates Antitumor Effects in Human Tumor Xenografts Following Oral Administration
Dean A. Heathcote, Hetal Patel, Sebastian H. B. Kroll, Pascale Hazel, Manikandan Periyasamy, Mary Alikian, Seshu K. Kanneganti, Ashutosh S. Jogalekar, Bodo Scheiper, Marion Barbazanges, Andreas Blum, Jan Brackow, Alekasandra Siwicka, Robert D. M. Pace, Matthew J. Fuchter, James P. Snyder, Dennis C. Liotta, Paul. S. Freemont, Eric O. Aboagye, R. Charles Coombes, Anthony G. M. Barrett, Simak Ali
Journal of Medicinal Chemistry, November 2010, American Chemical Society (ACS)
DOI: 10.1021/jm100732t